Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
AJNR. American Journal of Neuroradiology|April 4, 2009
The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancerJ A Eloy, E M Brett, G M Fatterpekar, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1997
Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinomaL Kostakoglu, U Uysal, E Ozyar, et al.Nuclear Medicine and Biology|January 1, 1996
Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: dosimetry calculations incorporating cross-organ beta dosesO Ugur, L Kostakoglu, E T Hui, et al.Gynecologic Oncology|October 1, 1993
Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX35 in patients with epithelial ovarian cancerS C Rubin, L Kostakoglu, C Divgi, et al.Cancer Investigation|January 1, 1994
Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody I-131-CC49L Kostakoglu, C R Divgi, S Hilton, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1995
Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinomaC R Divgi, A M Scott, L Dantis, et al.Clinical Nuclear Medicine|July 1, 1992
The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumorsC Caluser, H Macapinlac, J Healey, et al.European Journal of Nuclear Medicine|February 1, 1996
Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trialS C Grant, L Kostakoglu, M G Kris, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Pre- and post-therapy thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinomaL Kostakoglu, U Uysal, E Ozyar, et al.Nuclear Medicine and Biology|July 1, 1994
Current status of radioimmunotherapyS M Larson, C R Divgi, A Scott, et al.Pageof 4